Evidence map›Paper›PMID 36237976›Full record

ArticleHeliyon2022

Claudin-4 localization in epithelial ovarian cancer.

Margaret C Neville, Patricia G Webb, Heidi K Baumgartner, Benjamin G Bitler

Open access · goldAbstract read
In one paragraph

Article in Heliyon, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Margaret C NevilleDepartments of Obstetrics and Gynecology and Physiology and Biophysics, University of Colorado School of Medicine, Aurora, CO, 80845, USA.
Patricia G WebbDepartment of Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora, CO, 80845, USA.
Heidi K BaumgartnerUniversity of Colorado Anschutz Medical Campus, 2700 E. 19th Ave., Aurora, CO, 80045, USA.
Benjamin G BitlerDepartment of Obstetrics and Gynecology, Division of Reproductive Sciences, University of Colorado Denver Anschutz Medical Campus, Mail Stop 8613, 12700 E. 19 Ave., Aurora, CO, 80045, USA.
University of Colorado Anschutz Medical Campus · USUniversity of Colorado Denver · US

Funding

Targeting Wnt signaling in therapy-resistant ovarian cancerR37CA261987 · NCI · UNIVERSITY OF COLORADO DENVER · PI Benjamin G Bitler · 2021 to 2026
$2.4M
NCI NIH HHS R37 CA261987
6 · The paper itself

Abstract

Claudin-4, a protein with the structure of classic claudins most often found in cell-cell junctions, is frequently overexpressed in epithelial cancers where its localization has not been studied. In this study we aimed to find out where this membrane protein is localized in an ovarian tumor model, OVCAR3 cells, that express high levels of the protein. Immunohistochemical studies showed claudin-4 staining in a perinuclear region, at most plasma membranes and in cytoplasmic puncta. Native claudin-4 did not overlap with phosphorylated claudin-4, which was partially located in focal adhesions. Using claudin-4 BioID technology we confirmed that large amounts of claudin-4 are localized to the Golgi compartment, including in dispersed Golgi in cells where claudin-4 is partially knocked down and in dividing cells. Claudin-4 appears to be present in the vicinity of several types of cell-cell junctions, but there is no evidence that it forms tight junctions in these tumor cells. Both claudin-4, the Golgi marker GM130, and the plasma membrane receptor Notch2 were found in dispersed Golgi in dividing cells. This definition of the cellular architecture of claudin-4 should provide a framework for better understanding of the function of claudin-4 in tumor cells and its molecular interactions.

Indexed as

Cell architectureCell-cell contactsClaudin-4Endoplasmic reticulumEndosomeGolgiOvarian cancerPlasma membrane proteins

Identifiers

PMID36237976
PMCPMC9552118
OpenAlexW4300772594

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.